Entecavir hydrate, 97%, a nucleoside analog that inhibits reverse transcription

Name: Entecavir hydrate, 97%, a nucleoside analog that inhibits reverse transcription | 209216-23-9
Brand: J&K Chemical
SKU: JK794714_250_MG
Price: 265.4 USD
Availability: OutOfStock

Cat. No JK794714_250_MG

Vendor: J&K Chemical

Product Information

Product Name

Entecavir hydrate, 97%, a nucleoside analog that inhibits reverse transcription

Brand Name

J&K

Product Number

794714

CAS

209216-23-9

Molecular Formula

C12H15N5O3·H2O

Molecular Weight

295.29

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

2-Amino-1,9-dihydro-9-(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl-6H-purin-6-one monohydrate

PubChem CID

135526609

IUPAC Name

2-amino-9-(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl-1H-purin-6-one;hydrate

InChI Key

YXPVEXCTPGULBZ-WQYNNSOESA-N

SMILES

C=C1C@H(CC@@H(C@H1CO)O)N2C=NC3=C2N=C(NC3=O)N.O

Safety Information

Precautionary Statement

P262

References Data Source From Pubchem

An RP-HPLC Method for the Simultaneous Analysis of Selected Antiviral Drugs

Publication Name: Chromatographia

Publication Date: 2025-02-05

DOI: 10.1007/s10337-025-04386-8

Mycophenolate-mofetil/tacrolimus

Publication Name: Reactions Weekly

Publication Date: 2024-04-27

DOI: 10.1007/s40278-024-57730-1

Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2023-12-15

DOI: 10.1016/j.ejmech.2023.115919

Atezolizumab/bevacizumab

Publication Name: Reactions Weekly

Publication Date: 2023-06-24

DOI: 10.1007/s40278-023-41752-0

Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection

Publication Name: Bioorganic & Medicinal Chemistry Letters

Publication Date: 2022-11-01

DOI: 10.1016/j.bmcl.2022.128977

Entecavir hydrate, 97%, a nucleoside analog that inhibits reverse transcription

Product Information

General Information

Safety Information

References Data Source From Pubchem

An RP-HPLC Method for the Simultaneous Analysis of Selected Antiviral Drugs

Mycophenolate-mofetil/tacrolimus

Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis

Atezolizumab/bevacizumab

Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection